Silverarc Capital Management LLC acquired a new stake in shares of Relmada Therapeutics, Inc. (NASDAQ:RLMD – Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 100,000 shares of the company’s stock, valued at approximately $300,000. Silverarc Capital Management LLC owned […]
Relmada Therapeutics, Inc. (NASDAQ:RLMD – Get Free Report) CEO Sergio Traversa bought 31,541 shares of the firm’s stock in a transaction that occurred on Monday, January 29th. The stock was purchased at an average price of $3.71 per share, with a total value of $117,017.11. Following the completion of the purchase, the chief executive officer […]
In a recent transaction on January 31, 2024, CEO Sergio Traversa of Relmada Therapeutics Inc (NASDAQ:RLMD) purchased 100,000 shares of the company's stock, according to a SEC Filing.
By Stephen Nakrosis Shares of Relmada Therapeutics hit a 52-week high following news its chief executive and other executives recently purchased shares of.